HIV-specific T cells expressing an X5-GPI artificial receptor can suppress hiv replication in vitro: implications for a cure strategy for HIV-positive individuals with hematologic malignancies

• S. Patel,
• R.B. Jones,
• J. Kimata,
• C.M. Bollard,
• C.R. Cruz,
• S.-H. Huang,
• K. Wright,
• S. Albihani,
• A. Misra,
• P. Zhou,
• C. Russell Cruz

Affiliations

S. Patel

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA

R.B. Jones

Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA

J. Kimata

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA

C.M. Bollard

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA

C.R. Cruz

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA

S.-H. Huang

Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA

K. Wright

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA

S. Albihani

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA

A. Misra

Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA

P. Zhou

Unit of Anti-Viral Immunity and Genetic Therapy, Institut Pasteur of Shanghai-Chinese Academy of Sciences, Shanghai, China

C. Russell Cruz

Center for Cancer and Immunology Research, Children's National Health System, Washington, DC, USA; Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington DC, USA